CD79A and B-cell chronic lymphocytic leukemia: We have recently described, through the analysis of both human samples from B-CLL patients and our Rosa26-RRAS2fl/fl-mb1-Cre and Sox2-Cre mouse models, that overexpression of RRAS2 drives B-CLL development [46].